Clensta relying on waterless Covid-19 protection lotion
Considering the increased demand for anti-viral products across the globe, Clensta has developed 'Clensta Covid-19 Protection Lotion,' a 24x7 protection shield. The Lotion is effective in keeping one safe from the virus and is effective for 24 hours. The product is very easy to use and needs to be applied three times a day to secure 100 per cent protection from the virus, bacteria, and fungi. The Lotion is based on Prolonged Anti-viral Protection technology i.e. PAP Technology that provides prolonged protection from pathogenic microorganisms including Covid-19, flu virus, MRSA, and Candida Albicans for up to 24 hours. The Nano-Biotechnology Formulation-based product with first-of-its-kind patented PAP Technology is effective to prevent viral, bacterial, and fungal infections without harming human health. In an exclusive interview with Bizz Buzz, Puneet Gupta, CEO & Founder, Clensta International, elaborates on demand for anti-viral products
How would you describe your new anti-viral product? Is it a one-day vaccine or is it a strong sanitizer that lasts for a day?
The product is a breakthrough advancement in the formulation of engineering chemistry with first-of-its-kind PAP Technology that releases antimicrobial agents i.e. reactive oxygen species (ROS) at a controlled level for 24 hours and in turn protecting from 99.9 per cent disease-causing microbes (viruses, bacteria, & fungi).
Covid-19 protection lotion is an advanced bio-surfactant nanoparticle advancement in the formulation to prevent coronavirus infection without harming the environment and human health. In this well-engineered technology, a Biosurfactant has been accelerated for anti-microbial efficacy and stability using acid and silver nanoparticles mixture at a synergistic concentration. The product is a breakthrough advancement in the formulation of engineering chemistry with first of its kind PAP Technology that releases antimicrobial agents i.e. reactive oxygen species (ROS) at a controlled level for 24 hours and in turn protecting from 99.9 per cent disease-causing microbes.
What kind of target audience that you are looking to reach?
Our target audience is in line of our marketing model, which runs in two sectors either B2B or B2C. Hence, our marketing plans are integrated into two formats as follows:
B2C Audience B2B Audience: Large scale market and bigger target audience, Niche markets and smaller target audience. The strategy is to drive the target audience by emotions. Making the most of a rationally driven target audience. Generally, the goals are to strengthen transactional relationships with the customers, strengthen long-term business relationships, to reach the end-users and to convince all the decision-makers and dedicated business group.
Is it a bioproduct? is it effective enough for passengers flying for a day?
The product has been approved by the FDA & composed of skin-friendly ingredients to make it suitable for regular use on the whole body without any harmful effects. Interestingly, the product has been formulated and patented (PS) in such a way where the percentage of the active ingredients has proven efficacy against viruses (enveloped & non-enveloped), bacteria (gram +ve & gram –ve), and fungi. In a brief, it is a specially engineered formulation composed of three active ingredients that form a triplet complex of the vet. The nanoparticles in the triplet complex are accelerated to provide long-lasting antimicrobial protection by slowly releasing the reactive oxygen species (ROS) on the skin surface. The biosurfactant and acid mixture disrupts the outer membrane of the viruses, on the other hand, nanoparticles release ROS that degrades the genetic material (DNA/RNA) of the viruses and bacteria.
What are your sales projections for this product?
As far as the Indian ecosystem is concerned, the target market is worth Rs11,000 crores. Considering the importance of the product, the market would increase multiple folds across the globe. The market area is huge as it includes defence, hospitals, adventure enthusiasts and travellers, space, OTC & home care available at domestic & international scale. Our business is scaled from the aspect of B2B as well as B2C.
Although we do not have any other Indian company working in the exact same market with the exact same product, but since the product is a personal hygiene product at the end of the day. Any company dealing in soaps, body wash, sanitizers as well as shampoos, or dry shampoos can be considered as an indirect competitor. A very large segment of FMCG market leaders would eventually become competition given we are bringing in products or substitutes for all these products.
We have prepared our product using the ingredients that will break down in nature with high rate acceptable concentrations so that unacceptable concentrations of a surfactant or its metabolism are not generated in the environment.
Do you have any other products that complement Clensta?
Clensta as a brand had been established with the thought that we want to provide innovative solutions to everyday problems. Keeping one eye on the future, the company aims to develop environment-compassionate products that contribute to a better world.
In the portfolio, Clensta has developed a waterless body bath and shampoo that can be used for patients in hospitals, old age people, defence soldiers, and adventure enthusiasts to maintain their hygiene and take a bath without water. A simple formula that is free of alcohol, SLS, and any other harmful ingredients has been developed and can be used without water. It can be directly applied to hair and body, massaged, and then can be dried off using a towel. The product removes dirt, oil, and grease completely. It provides innovative healthcare solutions that make hygiene Quick, Accessible & Simple for everyone anytime and anywhere.
Do you plan to target the export market?
Our revenue model is driven by selling off these waterless products following a B2B and B2B2C sales channel for sales wherein the product is sold via a distribution network. In terms of distribution channel overseas, we have a well-connected distribution network in place that works closely towards making our product available to various market segments and other market areas resolving issues related to maintaining hygiene. Further to reach customers, we are building the channels of online shopping through various e-commerce portals.
The target market is worth Rs11,000 crores. Considering the importance of the product, the market would increase multiple folds across the globe. The market area is huge which includes defence, hospitals, adventure enthusiasts & travellers, space, OTC & home care available at domestic and international scale
Our revenue model aims at enhancing sales of our waterless products following a B2B and B2B2C sales channel via a distribution network. In terms of distribution channel overseas, we have a well-connected distribution network in place that works closely towards making our product available in all markets.